• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多形性胶质母细胞瘤DNA适配体的体外筛选

In vitro Selection of DNA Aptamers to Glioblastoma Multiforme.

作者信息

Bayrac Abdullah Tahir, Sefah Kwame, Parekh Parag, Bayrac Ceren, Gulbakan Basri, Oktem Huseyin Avni, Tan Weihong

机构信息

Department of Biotechnology, Nanobiotechnology Research and Development Group, Middle East Technical University, 06531 Ankara, TURKEY.

出版信息

ACS Chem Neurosci. 2011 Jan 31;2(3):175-181. doi: 10.1021/cn100114k.

DOI:10.1021/cn100114k
PMID:21892384
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3164477/
Abstract

Aptamer probes for specific recognition of glioblastoma multiforme were generated using a repetitive and broad cell-SELEX-based procedure without negative selection. The 454 sequencing technology was used to monitor SELEX, and bioinformatics tools were used to identify aptamers from high throughput data. A group of aptamers were generated that can bind to target cells specifically with dissociation constants (K(d)) in the nanomolar range. Selected aptamers showed high affinity to different types of glioblastoma cell lines, while showing little or no affinity to other cancer cell lines. The aptamers generated in this study have potential use in different applications, such as probes for diagnosis and devices for targeted drug delivery, as well as tools for molecular marker discovery for glioblastomas.

摘要

使用基于细胞指数富集的配体系统进化技术(cell-SELEX)的重复且广泛的程序,在没有阴性筛选的情况下,生成了用于特异性识别多形性胶质母细胞瘤的适配体探针。采用454测序技术监测细胞指数富集的配体系统进化技术(SELEX),并使用生物信息学工具从高通量数据中鉴定适配体。生成了一组解离常数(K(d))在纳摩尔范围内、能与靶细胞特异性结合的适配体。筛选出的适配体对不同类型的胶质母细胞瘤细胞系显示出高亲和力,而对其他癌细胞系的亲和力很小或没有。本研究中生成的适配体在不同应用中具有潜在用途,如用于诊断的探针、靶向给药装置,以及用于胶质母细胞瘤分子标志物发现的工具。

相似文献

1
In vitro Selection of DNA Aptamers to Glioblastoma Multiforme.多形性胶质母细胞瘤DNA适配体的体外筛选
ACS Chem Neurosci. 2011 Jan 31;2(3):175-181. doi: 10.1021/cn100114k.
2
An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.一种用于筛选与化脓性链球菌M11型结合的DNA适配体的改良SELEX技术。
Methods. 2016 Mar 15;97:51-7. doi: 10.1016/j.ymeth.2015.12.005. Epub 2015 Dec 8.
3
Evolution of DNA aptamers for malignant brain tumor gliosarcoma cell recognition and clinical tissue imaging.用于恶性脑肿瘤胶质肉瘤细胞识别和临床组织成像的DNA适配体的演变
Biosens Bioelectron. 2016 Jun 15;80:1-8. doi: 10.1016/j.bios.2016.01.031. Epub 2016 Jan 14.
4
DNA aptamers that target human glioblastoma multiforme cells overexpressing epidermal growth factor receptor variant III in vitro.体外靶向人表皮生长因子受体变体 III 过表达的多形性胶质母细胞瘤的 DNA 适体。
Acta Pharmacol Sin. 2013 Dec;34(12):1491-8. doi: 10.1038/aps.2013.137.
5
Selection of aptamers for molecular recognition and characterization of cancer cells.用于癌细胞分子识别与表征的适配体的筛选。
Anal Chem. 2007 Jul 1;79(13):4900-7. doi: 10.1021/ac070189y. Epub 2007 May 27.
6
Use of cell-SELEX to generate DNA aptamers as molecular probes of HPV-associated cervical cancer cells.使用细胞 SELEX 技术生成 HPV 相关宫颈癌细胞的 DNA 适体作为分子探针。
PLoS One. 2012;7(4):e36103. doi: 10.1371/journal.pone.0036103. Epub 2012 Apr 20.
7
Streamlining RNA Aptamer Selection via Unique Molecular Identifiers and High-Throughput Sequencing.通过独特分子标识符和高通量测序简化 RNA 适体选择。
Anal Chem. 2024 Oct 22;96(42):16686-16694. doi: 10.1021/acs.analchem.4c02984. Epub 2024 Oct 10.
8
Selection of DNA aptamers against glioblastoma cells with high affinity and specificity.高亲和力和特异性抗脑胶质瘤细胞的 DNA 适体的筛选。
PLoS One. 2012;7(10):e42731. doi: 10.1371/journal.pone.0042731. Epub 2012 Oct 2.
9
One-Pot SELEX: Identification of Specific Aptamers against Diverse Steroid Targets in One Selection.一锅法SELEX:在一次筛选中鉴定针对多种类固醇靶标的特异性适配体。
ACS Omega. 2019 Nov 20;4(23):20188-20196. doi: 10.1021/acsomega.9b02412. eCollection 2019 Dec 3.
10
Using live cells to generate aptamers for cancer study.利用活细胞生成适体用于癌症研究。
Methods Mol Biol. 2010;629:355-67. doi: 10.1007/978-1-60761-657-3_23.

引用本文的文献

1
Aptamer-Coated PLGA Nanoparticles Selectively Internalize into Epithelial Ovarian Cancer Cells In Vitro and In Vivo.适体包被的聚乳酸-羟基乙酸共聚物纳米颗粒在体外和体内均可选择性内化进入上皮性卵巢癌细胞。
Biomolecules. 2025 Aug 4;15(8):1123. doi: 10.3390/biom15081123.
2
An overview of Sgc8 aptamer as a potential theranostic agent for cancer with PTK7 oncogenic target.Sgc8适配体作为一种针对PTK7致癌靶点的癌症潜在诊疗试剂的概述。
Sci Prog. 2025 Jan-Mar;108(1):368504251325385. doi: 10.1177/00368504251325385.
3
AptamerRunner: An accessible aptamer structure prediction and clustering algorithm for visualization of selected aptamers.适体运行器:一种用于可视化所选适体的可访问的适体结构预测和聚类算法。
Mol Ther Nucleic Acids. 2024 Oct 9;35(4):102358. doi: 10.1016/j.omtn.2024.102358. eCollection 2024 Dec 10.
4
AptaDiff: de novo design and optimization of aptamers based on diffusion models.AptaDiff:基于扩散模型的适体从头设计与优化。
Brief Bioinform. 2024 Sep 23;25(6). doi: 10.1093/bib/bbae517.
5
AptamerRunner: An accessible aptamer structure prediction and clustering algorithm for visualization of selected aptamers.适体运行器:一种用于所选适体可视化的可访问的适体结构预测与聚类算法。
bioRxiv. 2023 Nov 15:2023.11.13.566453. doi: 10.1101/2023.11.13.566453.
6
Unravelling the Glioblastoma Tumour Microenvironment: Can Aptamer Targeted Delivery Become Successful in Treating Brain Cancers?解析胶质母细胞瘤肿瘤微环境:适体靶向递送能否成功用于治疗脑癌?
Cancers (Basel). 2023 Sep 1;15(17):4376. doi: 10.3390/cancers15174376.
7
Multiwalled Carbon Nanotubes as Nanomaterial Tool in the Management of Prostate Cancer: A Possible Nanoformulation Approach.多壁碳纳米管作为前列腺癌治疗中的纳米材料工具:一种可能的纳米制剂方法。
Adv Pharm Bull. 2022 May;12(3):509-514. doi: 10.34172/apb.2022.053. Epub 2021 Sep 29.
8
Selection and Application of Aptamer Affinity for Protein Purification.适体亲和性在蛋白质纯化中的选择与应用。
Methods Mol Biol. 2022;2466:187-203. doi: 10.1007/978-1-0716-2176-9_13.
9
Advances in aptamer-based nuclear imaging.基于适体的核医学成像进展。
Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2544-2559. doi: 10.1007/s00259-022-05782-0. Epub 2022 Apr 8.
10
Aptamer Applications in Neuroscience.适体在神经科学中的应用。
Pharmaceuticals (Basel). 2021 Dec 3;14(12):1260. doi: 10.3390/ph14121260.

本文引用的文献

1
DNA aptamers as molecular probes for colorectal cancer study.DNA 适体作为结直肠癌研究的分子探针。
PLoS One. 2010 Dec 10;5(12):e14269. doi: 10.1371/journal.pone.0014269.
2
Study of the molecular recognition of aptamers selected through ovarian cancer cell-SELEX.通过卵巢癌细胞 SELEX 筛选的适体的分子识别研究。
PLoS One. 2010 Nov 1;5(11):e13770. doi: 10.1371/journal.pone.0013770.
3
Aptamers recognizing glycosylated hemagglutinin expressed on the surface of vaccinia virus-infected cells.识别痘病毒感染细胞表面糖基化血凝素的适体。
Anal Chem. 2010 Oct 15;82(20):8642-9. doi: 10.1021/ac101801j.
4
Development of DNA aptamers using Cell-SELEX.使用细胞 SELEX 技术开发 DNA 适体。
Nat Protoc. 2010 Jun;5(6):1169-85. doi: 10.1038/nprot.2010.66. Epub 2010 Jun 3.
5
U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line.U87MG 解码:一条染色体结构异常的人类癌细胞系的基因组序列。
PLoS Genet. 2010 Jan 29;6(1):e1000832. doi: 10.1371/journal.pgen.1000832.
6
Aptamers generated from cell-SELEX for molecular medicine: a chemical biology approach.基于细胞 SELEX 的适体在分子医学中的应用:一种化学生物学方法。
Acc Chem Res. 2010 Jan 19;43(1):48-57. doi: 10.1021/ar900101s.
7
Generating aptamers for recognition of virus-infected cells.生成用于识别病毒感染细胞的适配体。
Clin Chem. 2009 Apr;55(4):813-22. doi: 10.1373/clinchem.2008.113514. Epub 2009 Feb 26.
8
Jalview Version 2--a multiple sequence alignment editor and analysis workbench.Jalview 2版本——一个多序列比对编辑器和分析工作台。
Bioinformatics. 2009 May 1;25(9):1189-91. doi: 10.1093/bioinformatics/btp033. Epub 2009 Jan 16.
9
Gene expression analysis of glioblastomas identifies the major molecular basis for the prognostic benefit of younger age.胶质母细胞瘤的基因表达分析确定了年轻患者预后良好的主要分子基础。
BMC Med Genomics. 2008 Oct 21;1:52. doi: 10.1186/1755-8794-1-52.
10
Differential sensitivity of human glioblastoma LN18 (PTEN-positive) and A172 (PTEN-negative) cells to Taxol for apoptosis.人胶质母细胞瘤 LN18(PTEN 阳性)和 A172(PTEN 阴性)细胞对紫杉醇诱导凋亡的敏感性差异。
Brain Res. 2008 Nov 6;1239:216-25. doi: 10.1016/j.brainres.2008.08.075. Epub 2008 Sep 4.